New SPAC FoxWayne Registers $50M IPO

FoxWayne Enterprises Acquisition filed with the SEC today to raise $50 million in an IPO.

The SPAC intends to target a biotechnology or telemedicine company in North America.

FoxWayne is led by Chairman, CEO and CFO Robb Knie, who is president, CEO and Chairman of Hoth Therapeutics, a biopharmaceuticals company.

The SPAC plans to list on the Nasdaq under FOXWU. Read more.

Total
0
Shares
Related Posts